The DOI matches its Crossref record; 29 of the 30 references it cites were found in a registry or an index.
Thuricin CD, a posttranslationally modified bacteriocin with a narrow spectrum of activity against Clostridium difficile
Open accessAbstract
The last decade has seen numerous outbreaks of Clostridium difficile-associated disease (CDAD), which presented significant challenges for healthcare facilities worldwide. We have identified and purified thuricin CD, a two-component antimicrobial that shows activity against C. difficile in the nanomolar range. Thuricin CD is produced by Bacillus thuringiensis DPC 6431, a bacterial strain isolated from a human fecal sample, and it consists of two distinct peptides, Trn-alpha and Trn-beta, that act synergistically to kill a wide range of clinical C. difficile isolates, including ribotypes commonly associated with CDAD (e.g., ribotype 027). However, this bacteriocin thuricin CD has little impact on most other genera, including many gastrointestinal commensals. Complete amino acid sequencing using infusion tandem mass spectrometry indicated that each peptide is posttranslationally modified at its respective 21st, 25th, and 28th residues. Solution NMR studies on [(13)C,(15)N] Trn-alpha and [(13)C,(15)N]Trn-beta were used to characterize these modifications. Analysis of multidimensional NOESY data shows that specific cysteines are linked to the alpha-carbons of the modified residues, forming three sulfur to alpha-carbon bridges. Complete sequencing of the thuricin CD gene cluster revealed genes capable of encoding two S'-adenosylmethionine proteins that are characteristically associated with unusual posttranslational modifications. Thuricin CD is a two-component antimicrobial peptide system with sulfur to alpha-carbon linkages, and it may have potential as a targeted therapy in the treatment of CDAD while also reducing collateral impact on the commensal flora.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“and administration of a cocktail containing a member of Lachnospiraceae was reported to cure CDI in mice52.”
From Update on Fecal Microbiota Transplantation 2015: Indications, Methodologies, Mechanisms, and Outlook (2015) · cites this paper as [52]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bacteriocins: Developing innate immunity for food
Cotter, P. D., Hill, C., & Ross, R. P. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1273 · Cited by 2,380 · cited 1×
“Although bacteriocins produced by LAB are the most widely investigated (9, 10), bacteriocins are also produced by most other Gram-positive (11–15) and Gram-negative (16, 17) bacterial species.”
BackgroundSelf-citationWishart, D. S., Bigam, C. G., Holm, A., Hodges, R. S., & Sykes, B. D. (1995) · Journal of Biomolecular NMR · doi:10.1007/bf00227471 · Cited by 1,628
Bacteriocins of lactic acid bacteria
Klaenhammer, T. R. (1988) · Biochimie · doi:10.1016/0300-9084(88)90206-4 · Cited by 1,539
Wishart, D. S., Bigam, C. G., Holm, A., Hodges, R. S., & Sykes, B. D. (1995) · Journal of Biomolecular NMR · doi:10.1007/bf00211764 · Cited by 1,012
Lantibiotics: structure, biosynthesis and mode of action
McAuliffe, O. (2001) · FEMS Microbiology Reviews · doi:10.1016/s0168-6445(00)00065-6 · Cited by 700 · cited 2×
“4% identity) and also share similar features with a number of other double glycine leaders in Class I [type-A(II)] and class II bacteriocins (22).”
BackgroundSelf-citationS-adenosylmethionine: nothing goes to waste
Fontecave, M., Atta, M., & Mulliez, E. (2004) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2004.03.007 · Cited by 604 · cited 1×
“These enzymes generally generate catalytic radicals through the reductive cleavage of AdoMet by combining SAM and an unusual iron sulfur cluster (4Fe-4S) (25).”
BackgroundNarrative Review: The New Epidemic of Clostridium difficile–Associated Enteric Disease
Bartlett, J. G. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-145-10-200611210-00008 · Cited by 599 · cited 1×
“difficile (PCR ribotype 027) (5, 7) adds urgency to the search for alternative treatments for CDAD.”
BackgroundSchneider, E. (1998) · FEMS Microbiology Reviews · doi:10.1016/s0168-6445(98)00002-3 · Cited by 514 · cited 1×
“A perfect Walker A consensus motif beginning at Gly33 was identified (GX2GXGKS/T), and a Walker B site (hhhD; h is any hydrophobic residue) was located in the region of amino acid 152 (23) The TrnG protein is predicted to function as the N-terminal hydrophobic integral membrane domain, including six transmembrane α-he…”
BackgroundGenomics of the group of organisms
RASKO, D., ALTHERR, M., HAN, C., & RAVEL, J. (2005) · FEMS Microbiology Reviews · doi:10.1016/j.femsre.2004.12.005 · Cited by 470
Identification of Clostridium difficile as a cause of pseudomembranous colitis.
George, R. H., Symonds, J. M., Dimock, F., Brown, J. D., Arabi, Y., Shinagawa, N., Keighley, M. R., Alexander-Williams, J., & Burdon, D. W. (1978) · BMJ · doi:10.1136/bmj.1.6114.695 · Cited by 451 · cited 1×
“difficile was recognized as a causative agent of nosocomial diarrhea in the 1970s (1), and is now a common occurrence, and cases of Clostridium difficile-associated disease (CDAD) are increasing both in numbers and severity in many parts of the world (2, 3).”
Background
Research works printed but not linked: 4
- ; Center for Infections Mandatory Surveillance Team Health Protection Agency Summary points and commentary on quarterly calendar year and financial year Clostridium difficile data derived from Mandatory Surveillance. January 2009. Available at http://www.hpa.org.uk/webw/HPAweb&HPAwebStandard/HPAweb_C/1195733750761?p=1179745282408. Accessed April 8 2010. (2009).
- 10.1016/j.fmrre.2004.12.005 · doi:10.1016/j.fmrre.2004.12.005 · Paper page
- 10.1111/j.1574-6976.2001.tb00579.x · doi:10.1111/j.1574-6976.2001.tb00579.x · Paper page
- 10.1111/j.1574-6976.1998.tb00358.x · doi:10.1111/j.1574-6976.1998.tb00358.x · Paper page
Cited by
Rethinking amide bond synthesis
Pattabiraman, V. R., & Bode, J. W. (2011) · Nature · doi:10.1038/nature10702 · Cited by 2,164
Arnison, P. G., Bibb, M. J., Bierbaum, G., Bowers, A. A., Bugni, T. S., Bulaj, G., Camarero, J. A., Campopiano, D. J., Challis, G. L., Clardy, J., et al. (2013) · Nat. Prod. Rep. · doi:10.1039/c2np20085f · Cited by 2,076
Self-citationPrecision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile
Buffie, C. G., Bucci, V., Stein, R. R., McKenney, P. T., Ling, L., Gobourne, A., No, D., Liu, H., Kinnebrew, M., Viale, A., et al. (2015) · Nature · doi:10.1038/nature13828 · Cited by 1,872
Bacteriocins—A viable alternative to antibiotics?
Cotter, P. D., Ross, R. P., & Hill, C. (2013) · Nature Reviews Microbiology · doi:10.1038/nrmicro2937 · Cited by 1,793
“The vancomycin-nisin(1-12) hybrid restores activity against vancomycin resistant enterococci.”
BackgroundSelf-citationMicrobiota-mediated colonization resistance against intestinal pathogens
Buffie, C. G., & Pamer, E. G. (2013) · Nature reviews. Immunology · doi:10.1038/nri3535 · Cited by 1,564
Metadata
- Authors
- Rea, M. C., Sit, C. S., Clayton, E., O'Connor, P. M., Whittal, R. M., Zheng, J., Vederas, J. C., Ross, R. P., & Hill, C.
- Affiliations
- Teagasc - The Irish Agriculture and Food Development Authority (IE)
- University of Alberta (CA)
- Biotechnology Department, Teagasc, Moorepark Food Research Centre, Fermoy, Ireland;
- University College Cork (IE)
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2010-04-30
- Volume
- 107
- Issue
- 20
- Pages
- 9352-9357
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC2889069
- OpenAlex
- W2069812362
- Cited by
- 530
- References
- 30
- Citations by year
- 2026: 20 · 2025: 28 · 2024: 34 · 2023: 30 · 2022: 46 · 2021: 41 · 2020: 44 · 2019: 39 · 2018: 39 · 2017: 34 · 2016: 30 · 2015: 32 · 2014: 32 · 2013: 22 · 2012: 21
- FWCI
- 16.74
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- University of Alberta
- Science Foundation Ireland
- Fondation pour la Recherche Médicale
- Alberta Heritage Foundation for Medical Research
- Natural Sciences and Engineering Research Council of Canada
- Topics
- Health Sciences › Medicine › Infectious Diseases › Clostridium difficile and Clostridium perfringens research
- Life Sciences › Immunology and Microbiology › Microbiology › Antimicrobial Peptides and Activities
- Life Sciences › Immunology and Microbiology › Applied Microbiology and Biotechnology › Microbial Natural Products and Biosynthesis
- Keywords
- bacteriocins, Clostridium difficile, Clostridium difficile-associated disease, Bacillus thuringiensis, post-translational modification, ribotype 027, ribosome-inactivating proteins, targeted antimicrobial therapy, commensal bacteria
- MeSH terms
- Amino Acid Sequence, Anti-Bacterial Agents, Bacillus thuringiensis, Bacteriocins, Feces, Humans, Molecular Sequence Data, Protein Processing, Post-Translational, S-Adenosylmethionine, Clostridioides difficile, Nuclear Magnetic Resonance, Biomolecular, Sequence Analysis, Protein, Tandem Mass Spectrometry
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Thuricin CD, a posttranslationally modified bacteriocin with a narrow spectrum of activity against Clostridium difficile. https://app.cochat.ai/papers/10.1073/pnas.0913554107
- The paper
- Rea, M. C., Sit, C. S., Clayton, E., O'Connor, P. M., Whittal, R. M., Zheng, J., Vederas, J. C., Ross, R. P., & Hill, C. (2010). Thuricin CD, a posttranslationally modified bacteriocin with a narrow spectrum of activity against Clostridium difficile. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.0913554107
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.